Skechers is going private. A definitive merger with 3G Capital was announced and is expected to close this September. But there’s more to the story. If you hold Skechers stock, read this before the September 5 election deadline.

In a transformative move that’s set to reshape the U.S. athletic retail landscape, DICK’S Sporting Goods is acquiring Foot Locker for a whopping $4.1 billion. The merger agreement gives shareholders cash or stock options and signals big changes ahead for consumers, investors, and the broader market. Here’s everything you need to know.

The Home Depot is acquiring GMS Inc. in an all-cash tender offer valued at $110 per share. This blog breaks down the deal, what it means for investors, and what steps shareholders need to take now.

Walgreens Boots Alliance has reached a turning point. Shareholders approved its $6.5 billion acquisition by Sycamore Partners, and the transaction is set to close on August 27, 2025. With the deal final, Walgreens stock will be delisted, marking the end of an era for the 120-year-old retail pharmacy giant.

Chevron has completed its high-profile $53 billion acquisition of Hess Corporation after nearly two years of negotiations, regulatory review, and shareholder involvement. This merger marks one of the largest in the oil and gas sector in recent years. Here's a full timeline of the deal, key developments, and what it all means for the future of the energy landscape.

The tech industry is about to witness one of its most significant mergers in recent history. Synopsys, a titan in semiconductor design, is acquiring Ansys, a leader in simulation software. With a deal valued at $35 billion, this merger is set to create a powerful force at the intersection of electronics and physics.

In a bold strategic move, Novartis is acquiring Regulus Therapeutics for up to $1.8 billion. The acquisition centers around farabursen, a novel RNA-based therapy poised to disrupt treatment options for a serious kidney condition called ADPKD. Here's a deep dive into what this merger means for the future of biotech and patient care.

The New Home Company and Landsea Homes have reached a definitive merger agreement valued at approximately $1.2 billion, under which Landsea shareholders will receive $11.30 per share in cash, representing a 61 percent premium to the May 12, 2025 closing price. Backed by Apollo Global Management, this all-cash deal will create a privately held, top-25 national homebuilder with a diversified, asset-light platform spanning ten high-growth markets.

Servotronics and TransDigm have amended their merger agreement to boost the cash tender offer price to $47.00 per share following an unsolicited acquisition proposal. Here is a detailed look at the timeline, mechanics, board endorsement, and what investors should consider.

SRM Entertainment has transformed itself into Tron Inc through a strategic reverse merger, backed by a $100 million equity infusion paid in TRX, a landmark advisory deal with TRON founder Justin Sun, and a blueprint for a TRX Treasury Strategy. In this article, we’ll explore the deal mechanics, what they mean for shareholders, and the path ahead as Tron Inc stakes its claim in the blockchain frontier.

In a landmark deal announced in May 2025, Kronos Bio, Inc. agreed to be acquired by Concentra Biosciences for $0.57 per share in cash plus one contingent value right per share. This comprehensive guide unpacks the transaction’s background, key terms, strategic drivers, and what it means for Kronos’s investors and the broader biotech mergers 2025 landscape.

Redfin and Rocket Companies have agreed to a major merger that could redefine digital real estate. Here's what investors and industry watchers need to know.

Nordstrom, once a fixture on public markets, is now officially private. As of May 2025, the Nordstrom family and Mexican retail giant El Puerto de Liverpool have wrapped up their all-cash $24.25/share acquisition. From deal details to strategic impacts, here’s the inside scoop.

OptiNose, Inc. is set to merge with Paratek Pharmaceuticals in a deal offering cash and CVR-based incentives. Here’s everything shareholders and market watchers need to know about the merger’s terms, timeline, and potential impact.

Whitecap Resources and Veren Inc. are joining forces in a $15 billion all-share merger, forming Canada’s largest light oil and condensate producer. Let’s break down what this means for the energy industry, investors, and the market’s future.

Bristol-Myers Squibb is set to acquire 2seventy bio in a $5.00 per share cash offer. With massive implications for shareholders, biotech innovation, and strategic growth, here's what you need to know about this major transaction.

Vacasa, a leading force in the vacation rental management sector, has officially accepted a sweetened acquisition offer from Casago, pricing shares at $5.30 each. This move signals a significant reshaping of the North American vacation rental landscape.

The merger between Aerovate Therapeutics and Jade Biosciences marks a pivotal moment in the biotech landscape, aiming to develop cutting-edge therapies for autoimmune diseases. Let’s dive into the strategic benefits and future outlook of this exciting collaboration.

Shift4 Payments, a leader in integrated payment processing solutions, has taken a bold step by acquiring Global Blue Group Holding AG. This strategic merger marks a new era for both companies, blending payment technology with international tax-free shopping expertise.

Amcor and Berry Global have secured the European Commission's green light for their game-changing merger, signaling a massive shift in the global packaging industry. Here's what you need to know about the deal, the market impact, and what's next.